JOURNAL ARTICLE
Perioperative complication rates of primary and repeat hysteroscopic endometrial ablations.
STUDY OBJECTIVE: To determine perioperative complication rates at primary and repeat endometrial ablations.
DESIGN: Prospective cohort study (Canadian Task Force classification II-2).
SETTING: Tertiary care teaching hospital.
PATIENTS: Seventy-five women who underwent a repeat ablation and 800 who had a primary ablation by the same surgeon (GAV) between 1990 and 2000 for a diagnosis of menorrhagia and/or dysmenorrhea.
INTERVENTIONS: Hysteroscopic ablation involving coagulation or resection of endometrium, and second ablation after failure of the first.
MEASUREMENTS AND MAIN RESULTS: Serious perioperative complications were uterine perforation, hemorrhage, excess fluid absorption, and genital tract burns. They occurred in 9.3% of repeat ablations compared with 2.05% of primary ablations (p = 0.006).
CONCLUSION: Repeat endometrial ablation has a significantly higher rate of perioperative complications than primary ablation.
DESIGN: Prospective cohort study (Canadian Task Force classification II-2).
SETTING: Tertiary care teaching hospital.
PATIENTS: Seventy-five women who underwent a repeat ablation and 800 who had a primary ablation by the same surgeon (GAV) between 1990 and 2000 for a diagnosis of menorrhagia and/or dysmenorrhea.
INTERVENTIONS: Hysteroscopic ablation involving coagulation or resection of endometrium, and second ablation after failure of the first.
MEASUREMENTS AND MAIN RESULTS: Serious perioperative complications were uterine perforation, hemorrhage, excess fluid absorption, and genital tract burns. They occurred in 9.3% of repeat ablations compared with 2.05% of primary ablations (p = 0.006).
CONCLUSION: Repeat endometrial ablation has a significantly higher rate of perioperative complications than primary ablation.
Full text links
Trending Papers
Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium-Glucose Co-transporter-2 Inhibitors.TouchREVIEWS in endocrinology. 2022 November
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app